ResearcherCentral South UniversityActive in the last 2 years
Xiaowei Liu
Matched on ORCID iD 0000-0002-1193-4277; OpenAlex author ID A5100390756. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial. Co-author DOI 10.3892/ol.2024.14293↗
- Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review. Last author DOI 10.1080/17474124.2022.2020643↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yifan Wang · 1 shared paper, 2022 · strength 0.26
- Lie Yao · 1 shared paper, 2024 · strength 0.16
- Xuefeng Xu · 1 shared paper, 2024 · strength 0.16
- Yaolin Xu · 1 shared paper, 2024 · strength 0.16
- Yuan Ji · 1 shared paper, 2024 · strength 0.16
- Yefei Rong · 1 shared paper, 2024 · strength 0.16
- Xi Guo · 1 shared paper, 2024 · strength 0.16
- Lili Wu · 1 shared paper, 2024 · strength 0.16
- Wenquan Wang · 1 shared paper, 2024 · strength 0.16
- Liang Liu · 1 shared paper, 2024 · strength 0.16
- Dansong Wang · 1 shared paper, 2024 · strength 0.16
- Wenhui Lou · 1 shared paper, 2024 · strength 0.16
- Dayong Jin · 1 shared paper, 2024 · strength 0.16
- Yuhong Zhou · 1 shared paper, 2024 · strength 0.16
- Tiantao Kuang · 1 shared paper, 2024 · strength 0.16
- Jing Liu · 1 shared paper, 2024 · strength 0.16
- Jun Zhang · 1 shared paper, 2024 · strength 0.16
- Deliang Fu · 1 shared paper, 2024 · strength 0.16
- Wenchuan Wu · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.